XML 46 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Share-based compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based compensation  
Schedule of weighted-average assumptions used in determining fair value of share based awards

The Company determines the fair value of share based awards at the grant date by using the Black-Scholes option-pricing model, and has utilized the “simplified” method, as prescribed by the SEC’s Staff Accounting Bulletin (“SAB”) No.110, Share-Based Payment, to compute expected lives of share based awards with the following weighted-average assumptions:

Years ended

    

    

December 31, 

2021

2020

Assumptions

 

  

 

  

 

Dividend yield

 

0

%  

0

%

Risk free interest rate

 

0.29%-0.85

%  

0.27%-0.29

%

Expected volatility

 

90%-101

%  

101%-103

%

Expected lives

 

2.5-5 years

 

2.75-5 years

 

Schedule of company's stock option plan

A summary of the activity for the Company’s Plans for the indicated periods is presented below:

    

    

Weighted  

Average

Stock Options and Stock Appreciation Rights

Shares

Exercise Price

Outstanding at December 31, 2019

 

7,042,377

$

1.01

-Cancelled

 

$

-Exercised

 

(1,967,562)

$

0.91

-Granted

 

254,700

$

1.11

Outstanding at December 31, 2020

 

5,329,515

$

1.06

-Cancelled

 

(133,257)

$

2.02

-Exercised

 

(3,076,489)

$

1.16

 -Granted (1)

 

484,254

$

1.82

Outstanding at December 31, 2021

 

2,604,023

$

1.03

(1) Options to purchase 463,754 shares were granted in 2021, all of which were vested immediately in 2021. In addition, 20,500 stock appreciation rights were granted in December 2021 with a six- month vesting period.

Schedule of weighted average contractual life and exercise price

The following is the weighted average contractual life in years and the weighted average exercise price at December 31, 2021 and 2020 of:

    

    

Weighted 

    

Average

Remaining

Weighted

Number of

Contractual

Average

December 31, 2021

Options

Life

Exercise Price

Options outstanding and vested

 

2,583,523

 

5.85

$

1.00

    

    

Weighted 

    

Average

Remaining

Weighted

Number of

Contractual

Average

December 31, 2020

Options

Life

Exercise Price

Options outstanding

 

5,329,515

 

3.55

$

1.06

Options vested

 

5,261,947

 

3.54

$

1.05

Options unvested

 

67,568

 

4.71

$

1.23

Schedule of intrinsic value

The intrinsic values of options vested and exercised during the years ended December 31, 2021 and 2020 were as follows:

    

2021

    

2020

Intrinsic value of options vested

$

1,481,858

$

393,952

Intrinsic value of options exercised

$

7,088,578

$

843,893